NO325020B1 - Immunanalyse som er spesifikk for pattedyr-gamma-BNP-derivater samt sett - Google Patents

Immunanalyse som er spesifikk for pattedyr-gamma-BNP-derivater samt sett Download PDF

Info

Publication number
NO325020B1
NO325020B1 NO20001273A NO20001273A NO325020B1 NO 325020 B1 NO325020 B1 NO 325020B1 NO 20001273 A NO20001273 A NO 20001273A NO 20001273 A NO20001273 A NO 20001273A NO 325020 B1 NO325020 B1 NO 325020B1
Authority
NO
Norway
Prior art keywords
bnp
antibody
mammalian
derivatives
immunoassay
Prior art date
Application number
NO20001273A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001273D0 (no
NO20001273L (no
Inventor
Hidehisa Asada
Hiroyuki Shimizu
Kazuaki Endou
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17152093&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO325020(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO20001273D0 publication Critical patent/NO20001273D0/no
Publication of NO20001273L publication Critical patent/NO20001273L/no
Publication of NO325020B1 publication Critical patent/NO325020B1/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/58Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20001273A 1997-09-11 2000-03-10 Immunanalyse som er spesifikk for pattedyr-gamma-BNP-derivater samt sett NO325020B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24668497 1997-09-11
PCT/JP1998/004063 WO1999013331A1 (fr) 1997-09-11 1998-09-10 Procede de dosage immunologique pour bnp

Publications (3)

Publication Number Publication Date
NO20001273D0 NO20001273D0 (no) 2000-03-10
NO20001273L NO20001273L (no) 2000-05-10
NO325020B1 true NO325020B1 (no) 2008-01-14

Family

ID=17152093

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001273A NO325020B1 (no) 1997-09-11 2000-03-10 Immunanalyse som er spesifikk for pattedyr-gamma-BNP-derivater samt sett

Country Status (13)

Country Link
US (1) US6828107B2 (de)
EP (1) EP1016867B1 (de)
JP (1) JP3516655B2 (de)
KR (1) KR100563358B1 (de)
CN (1) CN1161609C (de)
AT (1) ATE315228T1 (de)
AU (1) AU731858B2 (de)
CA (1) CA2304263C (de)
DE (1) DE69833118T2 (de)
DK (1) DK1016867T3 (de)
ES (1) ES2256952T3 (de)
NO (1) NO325020B1 (de)
WO (1) WO1999013331A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US20030219734A1 (en) * 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
US20040176914A1 (en) * 2001-04-13 2004-09-09 Biosite Incorporated Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
WO2003016910A1 (en) * 2001-08-20 2003-02-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7608406B2 (en) * 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
JP3691803B2 (ja) * 2002-03-14 2005-09-07 三洋化成工業株式会社 血液中の心不全マーカー定量方法
AUPS169202A0 (en) * 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
EP3072978B1 (de) 2002-05-09 2018-07-11 The Brigham and Women's Hospital, Inc. 1l1rl-1 als ein marker kardiovaskulärer krankheiten
FR2843396B1 (fr) * 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
US7135329B2 (en) * 2002-11-18 2006-11-14 Princeton Biomeditech Corporation Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
US7109023B2 (en) * 2002-11-18 2006-09-19 Princeton Biomeditech Corporation Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
PT1638443E (pt) 2003-06-20 2011-01-25 Mayo Foundation Isoformas de péptido natriurético cerebral
JP2007525213A (ja) * 2004-01-27 2007-09-06 コンピュゲン ユーエスエイ,インク. 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法
US20080182299A1 (en) * 2004-01-27 2008-07-31 Compugent Ltd. Novel brain natriuretic peptide variants and methods of use thereof
EP1756583B1 (de) * 2004-03-19 2010-10-27 Biomedica Medizinprodukte GmbH & Co KG Prognoseverfahren für kongestives herzversagen
AT500800B1 (de) * 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
WO2006031583A2 (en) * 2004-09-09 2006-03-23 Biosite Incorporated Methods and compositions for measuring canine bnp and uses thereof
US7731965B2 (en) * 2005-02-17 2010-06-08 Abbott Lab Human ring specific BNP antibodies
US20070207152A1 (en) 2005-11-09 2007-09-06 Brophy Susan E Human BNP immunospecific antibodies
US7939069B2 (en) 2005-11-09 2011-05-10 Abbott Laboratories Human BNP immunospecific antibodies
ES2351623T3 (es) 2006-04-24 2011-02-08 Critical Care Diagnostics, Inc. Predicción de la mortalidad y detección de una enfermedad grave.
PT2021796E (pt) * 2006-05-01 2012-04-19 Critical Care Diagnostics Inc Diagnóstico de doença cardiovascular
CN101501067B (zh) 2006-08-08 2013-01-16 梅约医学教育与研究基金会 利尿和利尿钠的多肽
US20080064045A1 (en) 2006-09-07 2008-03-13 Huaiqin Wu Biomarker fragments for the detection of human BNP
US20080108147A1 (en) * 2006-11-03 2008-05-08 Tie Wei Reduction of non-specific binding in immunoassays
WO2008095052A2 (en) 2007-01-30 2008-08-07 Loma Vista Medical, Inc., Biological navigation device
AT504942B1 (de) 2007-03-07 2009-08-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
FI20075251A0 (fi) 2007-04-13 2007-04-13 Hytest Oy Immunomääritys epästabiilien antigeenien määrittämiseksi
US20080280377A1 (en) * 2007-05-08 2008-11-13 Abbott Laboratories Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
US8357656B2 (en) * 2007-09-15 2013-01-22 Mayo Foundation For Medical Education And Research Natriuretic peptide receptor-C agonists
WO2009086126A2 (en) * 2007-12-21 2009-07-09 Mayo Foundation For Medical Education And Research Natriuretic polypeptides
DK2827152T3 (en) 2008-04-18 2016-09-12 Critical Care Diagnostics Inc PREDICTION OF RISK OF MAJOR ADVERSE HEART EVENTS
US9186488B2 (en) 2008-06-02 2015-11-17 Loma Vista Medical, Inc. Method of making inflatable medical devices
CN102334031B (zh) * 2008-12-08 2014-10-08 美艾利尔圣地亚哥有限公司 组合的尿钠肽检测
CN101923090A (zh) * 2009-06-10 2010-12-22 中国科学院电子学研究所 固定人体脑钠肽的光学敏感膜的制备方法
EP3552655B1 (de) 2010-07-13 2020-12-23 Loma Vista Medical, Inc. Aufblasbare medizinische vorrichtungen
AU2011285694B2 (en) 2010-08-04 2014-12-18 Idexx Laboratories, Inc. Detection of degradation products of canine NT-proBNP
US10188436B2 (en) 2010-11-09 2019-01-29 Loma Vista Medical, Inc. Inflatable medical devices
CA2856798A1 (en) 2011-05-31 2012-12-06 Idexx Laboratories, Inc. Detection of degradation products of feline nt-probnp
WO2013032784A1 (en) 2011-08-30 2013-03-07 Mayo Foundation For Medical Education And Research Natriuretic polypeptides
US9611305B2 (en) 2012-01-06 2017-04-04 Mayo Foundation For Medical Education And Research Treating cardiovascular or renal diseases
CN104737170A (zh) 2012-08-21 2015-06-24 重症监护诊断股份有限公司 多标记风险分层
CN112710852B (zh) * 2021-03-26 2021-08-03 上海美迪西生物医药股份有限公司 一种gnp多肽的检测试剂盒及检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2676114B2 (ja) * 1990-04-16 1997-11-12 塩野義製薬株式会社 hBNPを認識するモノクローナル抗体および該抗体を用いるhBNPの免疫測定法
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds

Also Published As

Publication number Publication date
EP1016867A4 (de) 2004-11-17
CA2304263C (en) 2008-07-29
NO20001273D0 (no) 2000-03-10
JP3516655B2 (ja) 2004-04-05
CN1161609C (zh) 2004-08-11
CN1278919A (zh) 2001-01-03
DK1016867T3 (da) 2006-05-22
EP1016867B1 (de) 2006-01-04
KR100563358B1 (ko) 2006-03-22
US20030157596A1 (en) 2003-08-21
DE69833118D1 (de) 2006-03-30
AU731858B2 (en) 2001-04-05
AU9001098A (en) 1999-03-29
US6828107B2 (en) 2004-12-07
EP1016867A1 (de) 2000-07-05
WO1999013331A1 (fr) 1999-03-18
KR20010023853A (ko) 2001-03-26
ATE315228T1 (de) 2006-02-15
DE69833118T2 (de) 2006-08-31
ES2256952T3 (es) 2006-07-16
NO20001273L (no) 2000-05-10
CA2304263A1 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
NO325020B1 (no) Immunanalyse som er spesifikk for pattedyr-gamma-BNP-derivater samt sett
Struck et al. Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients
JP4932714B2 (ja) コペプチンを使用する疾患の診断方法
US20130157311A1 (en) Methods of Determination of Activation or inactivation of Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) Hormonal Systems
US7534582B2 (en) Method for measuring the amount of natriuretic peptides in a sample
US7977072B2 (en) Sandwich immunoassay for identifying partial proANP peptides
US20100028921A1 (en) Risk stratification for acute coronary syndrome by means of fragments/partial peptides of provasopressin, especially copeptin or neurophysin ii
JP2005510234A (ja) ポリペプチドの定量
EP1816477A1 (de) Verwendung von natriuretischen Peptiden und Plazentawachstumsfaktorwerten zur Risikostratifizierung von für Herzstresstests ausgewählten Personen
JP5734547B2 (ja) 生物学的液体中のナトリウム利尿ペプチドのサンプリングのための方法、組成物、および装置
Wijbenga et al. Cardiac peptides differ in their response to exercise. Implications for patients with heart failure in clinical practice
JP4294961B2 (ja) 試料中の実効的な副甲状腺ホルモン活性の測定方法
Vesely et al. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and β2-microglobulin in patients with congestive heart failure
Ong et al. A highly specific radioreceptor assay for the active circulating form of atrial natriuretic factor in human plasma.
Špinarová et al. Prognostic impact of copeptin and mid-regional pro-adrenomedullin in chronic heart failure with regard to comorbidities
Jüppner et al. Radioimmunoassay for human osteocalcin using an antibody raised against the synthetic human (h37–49) sequence
US7226729B1 (en) Method for inhibiting degradation of brain natriuretic peptides

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees